Innate Pharma SA (FR:IPH) has released an update.
Innate Pharma SA is set to celebrate its 25th anniversary by hosting a hybrid scientific symposium on immunotherapy in collaboration with the Icahn School of Medicine at Mount Sinai. The event, titled ‘Next Generation Immunotherapy Discoveries,’ will feature leading experts in the field and take place both in-person in New York City and online on October 3, 2024. Prior to the symposium, Innate Pharma will conduct an Investor and Analyst Meeting to discuss the company’s therapeutic innovations.
For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.
